NFKB1 and cancer: In this review, we will summarize the progress of NF‐κB study focusing on the crucial roles of this transcriptional factor family in many aspects of inflammation and cancers in the last 35 years, highlighting NF‐κB as a potential therapeutic target for human inflammatory disease and cancer treatment.